Literature DB >> 23269181

The risk of mortality among young children hospitalized for severe respiratory syncytial virus infection.

Shelagh M Szabo1, Katherine L Gooch, Meagan M Bibby, Pamela G Vo, Ian Mitchell, Pamela Bradt, Adrian R Levy.   

Abstract

Respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI) is the leading cause of childhood morbidity. Although also an important cause of childhood mortality worldwide, the impact of key risk factors has not been established. A systematic review of 34 articles reporting case fatality rates in young children hospitalized for severe RSV LRTI, according to the presence of underlying RSV risk factors, was conducted. The weighted mean case fatality rate was 1.2% (range, 0-8.3%; median, 0%; n = 10) among preterm infants; 5.2% (range, 2.0-37.0%; median, 5.9%; n = 7) among children with CHD; and 4.1% (range, 0-10.5%; median, 7.0%; n = 6) among children with BPD. Case fatality estimates among children not at high risk (n = 6) ranged from 0% to 1.5% (weighted mean, 0.2%; median, 0.0%). Fatality during hospitalization for severe RSV LRTI is rare among children not at high risk, but occurs more commonly among children at higher risk of RSV LRTI.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23269181     DOI: 10.1016/S1526-0542(12)00095-4

Source DB:  PubMed          Journal:  Paediatr Respir Rev        ISSN: 1526-0542            Impact factor:   2.726


  17 in total

1.  Letters to the Editor.

Authors:  I Mitchell; B Paes; K Lanctot; Rupesh Chawla; Aaron Chiu; Marianna Mitchell; Cecil Ojah; April Price; Sandra Seigel; Amanda Symington
Journal:  Paediatr Child Health       Date:  2015 Nov-Dec       Impact factor: 2.253

2.  Letters to the Editor.

Authors:  Karen Chang; Dennis Gurwitz; Peter Azzopardi; Shaheen Doctor; Ronik Kanani; Constantine Petrou; Paul Meinert; Meera Umamaheswaran Kissoon
Journal:  Paediatr Child Health       Date:  2016 Jun-Jul       Impact factor: 2.253

Review 3.  Risk factors for mortality from acute lower respiratory infections (ALRI) in children under five years of age in low and middle-income countries: a systematic review and meta-analysis of observational studies.

Authors:  Michela Sonego; Maria Chiara Pellegrin; Genevieve Becker; Marzia Lazzerini
Journal:  PLoS One       Date:  2015-01-30       Impact factor: 3.240

4.  Viral coinfection in acute respiratory infection in Mexican children treated by the emergency service: A cross-sectional study.

Authors:  Jahaziel Diaz; Jaime Morales-Romero; Gustavo Pérez-Gil; Martín Bedolla-Barajas; Netzahualpilli Delgado-Figueroa; Rebeca García-Román; Omar López-López; Evelyn Bañuelos; Cristal Rizada-Antel; Roberto Zenteno-Cuevas; Ángel Ramos-Ligonio; Clara Luz Sampieri; Luis Gustavo Orozco-Alatorre; Silvia I Mora; Hilda Montero
Journal:  Ital J Pediatr       Date:  2015-04-18       Impact factor: 2.638

5.  Safety and immunogenicity of novel respiratory syncytial virus (RSV) vaccines based on the RSV viral proteins F, N and M2-1 encoded by simian adenovirus (PanAd3-RSV) and MVA (MVA-RSV); protocol for an open-label, dose-escalation, single-centre, phase 1 clinical trial in healthy adults.

Authors:  C A Green; E Scarselli; M Voysey; S Capone; A Vitelli; A Nicosia; R Cortese; A J Thompson; C S Sande; Catherine de Lara; P Klenerman; A J Pollard
Journal:  BMJ Open       Date:  2015-10-28       Impact factor: 2.692

6.  Infection-related hospitalizations over 30 years of follow-up in patients starting renal replacement therapy at pediatric age.

Authors:  Danilo Lofaro; Judith L Vogelzang; Karlijn J van Stralen; Kitty J Jager; Jaap W Groothoff
Journal:  Pediatr Nephrol       Date:  2016-02       Impact factor: 3.714

7.  Respiratory syncytial virus-associated hospitalizations over three consecutive seasons in children with congenital heart disease.

Authors:  B Resch; S Kurath-Koller; J Hahn; W Raith; M Köstenberger; A Gamillscheg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-04-28       Impact factor: 3.267

8.  Mortality in children hospitalised with respiratory syncytial virus infection in Singapore.

Authors:  Ming Wei Lee; Anne En Goh
Journal:  Singapore Med J       Date:  2020-05-27       Impact factor: 1.858

Review 9.  Revised recommendations concerning palivizumab prophylaxis for respiratory syncytial virus (RSV).

Authors:  Lina Bollani; Eugenio Baraldi; Gaetano Chirico; Andrea Dotta; Marcello Lanari; Antonello Del Vecchio; Paolo Manzoni; Antonio Boldrini; Piermichele Paolillo; Sandra Di Fabio; Luigi Orfeo; Mauro Stronati; Costantino Romagnoli
Journal:  Ital J Pediatr       Date:  2015-12-15       Impact factor: 2.638

10.  Admission to hospital for bronchiolitis in England: trends over five decades, geographical variation and association with perinatal characteristics and subsequent asthma.

Authors:  Christopher A Green; David Yeates; Allie Goldacre; Charles Sande; Roger C Parslow; Philip McShane; Andrew J Pollard; Michael J Goldacre
Journal:  Arch Dis Child       Date:  2015-09-04       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.